Crystalline pharmaceutical and methods of preparation and use thereof
US9353088B2 · kind B2 · utility
21Cited by
65References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 1, 2014 |
| Grant date | May 31, 2016 |
| Priority date | — |
| Expiry date | Dec 1, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.